Here, a subpopulation of CXCR5+PD‐1+ cytotoxic T cells was identified with high TIM‐3, ICOS, and CD45RO expression in the lymph nodes from breast cancer patients but showed limited association with the clinical features of the patients. The gene discussed is CXCR5; the disease is breast carcinoma.